Neutrophil activation in fibrosing alveolitis: A comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis

European Respiratory Journal

Volumn 9, Issue 5, 1996, Pages 992-999

  Cailes, J B ^a   O'Connor, C ^b   Pantelidis, P ^a   Southcott, A M ^a   Fitzgerald, M X ^b   Black, C M ^c   Du Bois, R M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Bronchoalveolar lavage; fibrosing alveolitis; neutrophil enzymes; systemic sclerosis

Indexed keywords

LEUKOCYTE ENZYME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ASSAY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE MIGRATION; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC SCLEROSIS;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PULMONARY FIBROSIS; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC;

EID: 0029977421     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09050992     Document Type: Article

References (34)

1. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994; 150: 462-468.
2. Turner-Warwick M, Haslam PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987; 135: 26-34.
3. Haslam PL, Turton CW, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980; 35: 328-339.
4. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135: 696-704.
5. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 655-659.
6. Carre PC, Mortenson RL, King TE Jr, Noble PW, Sable CL, Riches DW. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis: a potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 1991; 88: 1802-1810.
7. Standiford TJ, Rolfe MW, Kunkel SL, et al. Macrophage inflammatory protein-1α expression in interstitial lung disease. J Immunol 1993; 151: 2852-2863.
8. Ozaki T, Hayashi H. Tani K, Ogushi F, Yasuoka S, Ogura T. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 145: 85-91.
9. Southcott AM, Jones KP, Li D, et al. Interleukin-8 and fibrosing alveolitis: differential expression in lone fibrosing alveolitis and fibrosing alveolitis in systemic sclerosis. Am J Respir Crit Care Med 1995; 151: 1604-1612.
10. Crystal RG, Bitterman PB, Rennard ST, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310: 154-165 and 235-244.
11. Harrison NK, Myers AR, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991; 144: 706-713.
12. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994; 149: 1583-1590.
13. Gadek JE, Kelman JA, Fells GA, et al. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med 1979; 301: 737-742.
14. Hallgren R, Bjermer L, Lundgren R, Venge P. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 1989; 139: 373-377.
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
16. Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory manual of neutrophil function. New York, Raven Press, 1986; pp. 150-151.
17. 1-proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993; 148(1): 1665-1670.
18. Gisslow MT, McBride BC. A rapid and sensitive collagenase assay. Anal Biochem 1975; 68: 70-78.
19. Kolsto-Otnaess AB, Meberg A, Sande HE. Plasma lactoferrin measured by an enzyme-linked immunosorbent assay (ELISA). Scand J Haematol 1983; 31: 235-240.
20. Denison DM, Cramer DS, Hanson PJ. Lung function testing and AIDS. Respir Med 1989; 83: 133-138.
21. Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987; 135: 250-263.
22. Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990; 88: 470-476.
23. Behr J, Maier K, Krombach F, Adelmann-Grill BC. Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis. Am Rev Respir Dis 1991; 144: 146-150.
24. Maier K, Leuschel L, Costabel U. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 143: 271-274.
25. O'Connor C, Odium C, van Breda A, Power C, FitzGerald MX. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax 1988; 43: 393-400.
26. Christner P, Fein A, Goldberg S, Lippmann M, Abrams W, Weinbaum G. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 131: 690-695.
27. Gilligan DM, O'Connor CM, Ward K, Moloney D, Bresnihan B, FitzGerald MX. Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 1990; 45: 591-596.
28. Idell S, Kucich U, Fein A, et al. Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132: 1098-1105.
29. Ward K, O'Connor CM, Odium C, Power C, FitzGerald MX. Pulmonary disease progress in sarcoid patients with and without bronchoalveolar lavage collagenase. Am Rev Respir Dis 1990; 142: 636-641.
30. Weiland JE, Garcia JG, Davis WB, Gadek JE. Neutrophil collagenase in rheumatoid interstitial lung disease. J Appl Physiol 1987; 62: 628-633.
31. Gadek JE. Adverse effects of neutrophils on the lung. Am J Med 1992; 92: 27S-31S.
32. O'Connor CM, FitzGerald MX. Matrix metalloproteases and lung disease. Thorax 1994; 49: 602-609.
33. Lynch JP, Standiford TJ, Rolfe MW, Kunkel SL, Strieter RM. Neutrophilic alveolitis in idiopathic pulmonary fibrosis: the role of interleukin-8. Am Rev Respir Dis 1992; 145: 1433-1439.
34. 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 1992; 145: 651-656.